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A STUDY OF EFFICIENCY OF AUTOLOGOUS 
PLATELET RICH PLASMA IN MYRINGOPLASTY 
  
                                     INTRODUCTION 
 
                        Chronic suppurative otitis media is defined as chronic 
inflammation of the mucoperiosteal lining of the middle ear cleft. It is 
associated with a persistent or intermittent infected discharge through a 
non intact tympanic membrane.               
                         It is prevalent in developing countries like India and is 
more common in lower socio economic groups. The incidence is very high 
among rural population than in urban population.
 (7) 
The overall prevalence 
rate is 46 and 16 persons per thousand in rural and urban population.    
                       Chronic otitis media (COM) is the term that equates with 
classic term “chronic suppurative otitis media” which is no longer 
advocated as there is no pus in all case of chronic otitis media. They are 
now divided into active COM where there is production of pus and 
inactive COM where there is no pus but can become active at times.
 (1) 
                      The diagnosis of chronic otitis media implies that there is 
permanent abnormality of pars tensa or flaccida which results from 
previous acute otitis media or negative middle ear pressure or otitis media 
with effusion. The clinical presentation of chronic otitis media varies with  
 
severity of infection, host response, and the time course over which it 
manifests.
 (11) 
 
Chronic otitis media (COM) is classified as follows
 (1) 
 
Types  Synonyms  Findings  
Healed COM  Tympanosclerosis / 
healed perforation 
Thinning or opacification of 
pars tensa without 
perforation or retraction. 
Inactive (Mucosal) 
COM 
Perforation Permanent perforation of 
pars tensa without 
inflammation of middle ear 
mucosa. 
Inactive(Squamous) 
COM 
Retraction Retraction of pars flaccida 
or tensa (in the 
posterosuperior quadrant) 
that can become active with 
retained debris. 
Active (Mucosal) 
COM 
 Permanent defect in the pars 
tensa with inflammation of 
middle ear mucosa that can 
discharge mucopus. 
Active (squamous) 
COM 
Cholesteatoma Retraction of pars flaccida 
and tensa which has 
retained squamous epithelial 
debris and associated with 
inflammation and 
production of pus. 
 
 
PATHOLOGY OF CHRONIC OTITIS MEDIA
 (1) 
                
                      Various histopathological changes occurring in middle ear 
and mastoid in case of COM are due to direct result of infection and 
inflammation and due to host response to the disease process. 
                      In inactive mucosal type of COM or dry perforation there is 
permanent perforation seen in the tympanic membrane without 
inflammation of middle ear mucosa. The fibrous tissue in the lamina  
 
 
propria gets thickened around the perforation. Usually the squamous 
epithelium migrates medially into mucosal layer to some extent. 
                     In Active mucosal COM there will be perforation with 
ottorrhea. Chronic inflammation of the mucosa of the middle ear leads to 
edema,submucosal fibrosis, hypervascularity, inflammatory cell infiltrates. 
There are areas of mucosal ulceration and granulation tissue formation. 
The subepithelial layer of the middle ear gets thickened by inflammatory 
edema. Mucoperiosteum is infiltrated by lymphocytes. Mucoperiosteum 
will appear polypoid. Progression of these mucosal changes can lead to 
formation of aural polyps which protrudes through the perforated tympanic 
membrane. This type of COM can lead to resorption of part or all ossicles 
called as resorptive osteitis. Long process of incus is commonly affected 
followed by stapes crura, body of incus and manubrium. Inflammatory 
mediators like interleukin-1, interleukin-6, tumour necrosis factor, 
prostaglandins, neurotransmitters and nitric oxide leads to pathological 
process of disease. Tympanosclerotic patch can occur over the tympanic 
membrane or in the middle ear. It is actually hyaline degeneration of the 
mucoperiosteum which is followed by calcification and ossification. It  
 
 
appears as chalky white plaque over the tympanic membrane and as drops 
of cooled candle wax in the middle ear and can fix the ossicles. 
              In inactive squamous COM there is retraction pocket due to static 
negative middle ear pressure. Retraction pocket is an invagination of the 
part of ear drum into the middle ear space which might be fixed or mobile. 
Epidermization is an advanced stage of retraction where middle ear 
mucosa is replaced by keratinizing squamous epithelium without 
accumulation of keratin debris. 
                     In active squamous type of COM there is cholesteatoma 
formation which is characterized by retention of keratin debris. Due to 
retraction the normal migratory pattern of the squamous epithelium is 
disrupted. It leads to the accumulation of keratin debris. Chronic infection 
and inflammation in the sac leads to biochemical changes in the local 
environment which leads to further growth and migration of the squamous 
epithelium and increased osteoclastic bone resorption. The local 
inflammation causes mucosal edema and retention of secretion which can 
further promote infection and this vicious cycle continues. Both 
mucoperiosteum and underlying bone are affected in the disease process. 
There is regular osteitic bone erosion mainly involving the postero- 
 
superior bony canal wall, scutum and ossicles. In addition erosion can 
involve any walls of the middle ear cleft, even the bony labyrinth. These 
defects are usually covered with inflammatory vascular granulations and 
there will be new bone formation.  
                       Chronic otitis media results from long term Eustachian tube 
dysfunction with a poorly aerated middle ear space, multiple bouts of 
acute otitis media, persistent middle-ear infection or other chronic 
inflammatory stimulus. The Eustachian tube appears to be the important 
one in pathogenesis of all forms of COM.  
                      The normal physiological functions of Eustachian tube are  
1. Maintain the middle ear gaseous pressure at the level that approximates 
atmospheric pressure. 
2. Prevents reflux of nasopharyngeal contents into middle ear cleft. 
3. Mucociliary clearance of middle ear secretion 
 
                  
 
                     Both anatomical and functional obstruction of the Eustachian 
tube can lead to failure of these functions which can result in otitis media.  
                     In our study we analyze the case of chronic otitis media 
mucosal type only which is one of the common diseases seen in ENT 
OPD. Tympanic membrane perforation may result from AOM, chronic 
otitis media, or trauma (injury or surgery). In some instances, a dry, simple 
perforation results from a single episode of AOM (i.e., necrotizing otitis 
media). Perforation of the tympanic membrane, especially involving the 
tympanic annulus, may allow in growth of the keratinizing epithelium of 
the ear canal or tympanic membrane, leading to cholesteatoma. 
                      These are the mechanisms by which persistent tympanic 
membrane perforation can occur 
1. Majority of cases are following an attack of acute otitis media following 
which tympanic membrane has failed to heal. 
2. Chronic otitis media with effusion can lead to degeneration of fibrous 
layer of tympanic membrane with subsequent thinning which predisposes 
to perforation and prevents spontaneous healing 
 
3. Following large traumatic perforations 
4. Following extrusion of tympanostomy tube. 
                       The primary symptom is conductive hearing loss, but it can 
also present with ottorhea, aural fullness, otalgia, and tinnitus. 
                      By the following two mechanisms tympanic membrane 
perforation can lead to repeated middle ear infections 
1. Bacteria can contaminate the middle ear directly from the external 
auditory canal through the perforated tympanic membrane 
2. The intact tympanic membrane usually has a middle ear gas cushion 
which helps to prevent the reflux of nasopharyngeal secretion into 
middle ear which will be lost in perforation 
 
MANAGEMENT: 
                   Before starting any antimicrobial therapy a swab of the 
discharge should be sent for culture and sensitivity. The commonly  
 
isolated bacteria in COM are pseudomonas aeruginosa, Staphylococcus 
aureus and the proteus species.
(7) 
                      Audiological evaluation is necessary to assess the type and 
degree of hearing loss. Usually most of the patient will have associated 
conductive hearing loss. As potentially ototoxic ear drops are often used it 
is very important to record the hearing before starting the treatment. 
                    Radiological investigations particularly X-ray of both 
mastoids is useful to compare the cellularity of the mastoids. Computed 
tomography scans are very useful in demonstrating the bony anatomy and 
are very important if intracranial complications are suspected. 
                      The aim of treatment in mucosal type of COM is to eliminate 
infection, to prevent further infection and to restore normal functioning of 
middle ear
(7)
. There are various nonsurgical and surgical measures 
available in achieving these aims. 
                        Nonsurgical measures include aural toileting, use of topical 
and systemic antibiotics. Topical antibiotics are more effective than 
systemic antibiotics in treating mucosal disease. Some cases of mucosal  
 
type COM resolve with medical management itself and usually no further 
intervention is needed if the patient is asymptomatic. 
                    If there is recurrence or persistence of ottorhea despite the 
medical treatment or if the patient is handicapped by conductive hearing 
loss surgical treatment should be considered. Ideal surgical procedure that 
has to be done is tympanoplasty after adequate control of infection and 
after the middle ear mucosa has become healthy. In this situation the 
chance of successful outcome is very high. Usually tympanic membrane 
perforation can be closed by doing a procedure called myringoplasty 
which can be combined with /without ossicular chain repair 
(tympanoplasty). In resistant cases which were refractory to medical 
management, tympanoplasty is usually combined with cortical 
mastoidectomy. In this procedure the aim is to aerate the middle ear and 
mastoid, remove chronically inflamed tissue; repair the tympanic 
membrane and ossicular chain.  
 
 
 
 
 
HISTORY OF MASTOID SURGERY
 (2). 
 
                   Mastoid Surgery developed as a treatment for suppurative ear 
disease. Infections of the ear were recorded as early as 380 BC in the 
Hippocratic era. In 16th century, Fabricius Hildanus reported a case of 
spontaneous drainage from a post auricular abscess for which he 
advocated early incision and drainage. Riolan in 1649 described a 
procedure similar to mastoidectomy, and John Luis Petit was the first 
person to perform the surgical trephination of the mastoid in 1774. Petit 
described exposing the mastoid cortex, performing a trephination, and then 
enlarging the surgically created fistula. Schwartze repopularized the 
operation in 1873. Since then, technologic advancements such as the 
operating microscope, the high-speed drill, and specialized microsurgical 
instruments have led to significant advances in the treatment of mastoid 
disease. Regions of the skull base previously thought to be inaccessible 
such as the petrous apex, the course of the facial nerve, the endolymphatic 
sac, and the cerebellopontine angle were now within reach. 
 
 
 
MYRINGOPLASTY 
                Various graft materials are available for closing the tympanic 
membrane perforation. Most commonly used grafting material is 
temporalis fascia graft. Other materials that can be used are vein, areolar 
tissue over temporalis fascia, tragal perichondrium, periosteum over 
mastoid process, meatal skin from bony external auditory meatus, split 
skin, fat, cartilage, xenografts like bovine pericardium and treated acellular 
dermal homograft’s etc can be used(11). 
                         There are various approaches used for myringoplasty like 
endaural approach, post auricular approach and transcanal approach.  
                         Endaural approach is usually indicated for small and 
medium sized perforations of the tympanic membrane with good hearing 
and dry ear. If the anterior edge of the perforation is concealed by the 
anterior meatal wall then this approach can be used.  
                          Post auricular approach is usually indicated for large 
perforation extending widely into the anterior edge of the tympanic 
membrane. This approach was done in majority of our cases. 
                       
 
 
                       Transcanal approach is used for smaller perforations in the 
posterior quadrant, especially when the size of the ear canal is large. The 
procedure is done using the microscope or endoscope. This approach 
eliminates the need for mastoid dressing, postaural pain, hematoma and 
infection. There are two popular grafting techniques underlay and overlay 
technique. In our study we did underlay myringoplasty. 
                        Failures do occur following this procedure due to 
displacement of graft and improper closure leading to residual perforation. 
To improve the graft take up rate various biomaterials or biological tissues 
like autologous serum, autologous platelet rich plasma, epidermal growth 
factor, alloderm, merogel, embryonic stem cell, royal jelly, seprafilm, 
chitosan patch, silk patch are used during myringoplasty with varying 
results. 
 
PLATELET RICH PLASMA (PRP): 
                              Recently biological material obtained from the patient is 
used with varying success rates. In our study we have planned to use 
platelet rich plasma because it is an autologous platelet rich concentrate 
which is available from patient own blood. By concentrating the platelets  
 
we can increase the growth factors. Application of this platelet rich plasma 
during myringoplasty can prevent the graft displacement and can also 
promote the faster healing of the perforation thereby improving and 
hastening the outcome.
(3) 
                            Platelet rich plasma was first used in cardiothoracic 
surgery. M.ferari used platelet rich plasma in 1987 after an open heart 
surgery. Now it is widely used in various fields like dentistry, orthopedics, 
otorhinolaryngology, maxillofacial surgery, dermatology, plastic and 
cosmetic surgery, urology, wound healing etc.  
                               The role of tissue oxygenation in wound healing was 
established and extensively investigated during 1980’s. Tissue 
oxygenation helps in increasing phagocytic and bactericidal activity of the 
host cell as well as helps in synthesis of collagen and other proteins. 
Moreover there is strong link between tissue oxygenation and growth 
factors which has been well established
 (17)
. Platelets isolated from the 
blood forms a rich autologous source of growth factors. When these 
platelets are concentrated and applied to the surgical site, more predictable 
outcome can be expected. Platelet rich plasma is such an autologous 
platelet concentrate. A blood clot is the important factor in soft tissue  
 
healing in all natural wounds. Platelet rich plasma is a similar strategy 
where platelet concentrate which is an enriched natural blood clot is 
produced which initiate a more rapid and complete healing process. A 
natural blood clot usually contains 95% RBC’s, 5% platelets, and less than 
one percent of white blood cells and numerous amount of fibrin strands. A 
platelet rich plasma blood clot contains 95% of platelet, 4% of RBC’s and 
1% of WBC’s. (17)  
                          Earlier recombinant growth factors were used commonly 
for soft tissue and bone healing. The use of PRP in place of these 
recombinant growth factors has several advantages. The growth factors 
obtained from platelets are autologous; upon degranulation they have 
specific action on the tissues and also interact with other growth factors in 
the body which results in gene activation and specific protein production. 
So the properties of PRP are based on the production and release of 
multiple growth factors and differentiation factors that are released upon 
platelet activation. These factors play an important role in cellular process 
like chemotaxis, mitogenesis, differentiation and metabolism.  
 
                        
 
The following growth factors are released from platelets upon 
degranulation 
 
1. Platelet derived growth factors (PDGF) 
 They are released by platelets, macrophages, monocytes, 
endothelial cells and smooth muscle cells. 
 Stimulates DNA and protein synthesis. 
 
2. Transforming growth factor beta (TGF-b) 
 Released platelets, T-Lymphocytes, neutrophils, macrophages 
and monocytes. 
 Stimulates angiogenesis and endothelial chemotaxis. 
 
3. Platelet derived angiogenesis factor (PDAF) 
 Released by platelets, endothelial cells, chondrocytes and 
macrophages. 
 Mitogenic effect on endothelial cells 
 Increases vessel permeability and angiogenesis. 
 
 
4. Insulin like growth factor-1 (IGF-1) 
 Released by platelets, osteoblasts and macrophages. 
 Enhances rate and quality of wound healing. 
 
5. Platelet factor -4 (PF-4) 
 Released by platelets 
 Chemo attractant for fibroblasts and neutorphils 
 
6. Interleukin 8 
7. Epidermal growth factor 
8. Fibroblast growth factor 
9. Connective tissue growth factor 
10. Insulin-like growth factor 2 
11. Vascular endothelial growth factor 
12. Keratinocyte growth factor 
The above mentioned growth factors are small proteic fragments 
belonging to cytokine group. Cytokines usually join to the membrane 
receptors which results in activation or inhibition of cellular functions. A 
type of regeneration which is specific for the tissue is produced. They  
intervene in intercellular communication, needed function of the moment, 
type of cells surrounding them and their location at that moment. 
Fibroblasts get activated by the influence of these platelets. The platelet 
derived growth factor stimulates cell proliferation, fibroblast chemotaxis 
and collagen synthesis. The transforming growth factor controls cell 
proliferation, it has intrinsic inflammatory activity and increases 
extracellular matrix formation and tissue repair. The epidermal growth 
factor promotes keratinocyte production, fibroblast chemotaxis, it 
stimulates angiogenesis and a provisional matrix formation. In short the 
growth factors promote regeneration of new functional tissue that is 
similar to the original one.  
                       Now it is well understood that platelets have many functions 
beyond simple hemostasis. Whitman et al cites PRP an “autologous 
alternative to fibrin glue” (17). Fibrin glue is obtained from the blood bank 
donations and it has been used for many years as haemostatic agent and 
surgical adhesive. The difference in composition between PRP and Fibrin 
Glue is presence of a very high concentration of platelets and patient’s 
own fibrinogen in PRP. 
 
 
PREPARATION OF PRP: 
PRP can be prepared by two techniques. 
      1. General-purpose cell separators 
      2. Platelet-concentrating cell separators 
 
1. General-purpose cell separators: 
                    They require large amount of blood (450 ml) and requires 
good hospital setup. Blood is drawn into the collection bag which contains 
citrate phosphate-dextrose anticoagulant and is first centrifuged at 5,600 
rpm to separate RBCs from platelet-poor plasma (PPP) and PRP. Next the 
centrifugation speed is reduced to 2,400 rpm and final separation of about 
30 ml of PRP is obtained from the RBCs. The remaining PPP and RBCs 
can be returned to the patient's body or can be discarded. 
 
2. Platelet-concentrating cell separators: 
                         They require small quantity of blood and can be prepared 
by in clinic itself. The preparation and the processing of PRP is similar in 
most of the platelet-concentrating systems but the anticoagulant used and  
 
 
the speed and duration of centrifugation might differ with different 
systems. 
1. Venous blood is taken into a tube containing an anticoagulant which 
avoids platelet activation and degranulation. 
2. The first centrifugation is a "soft spin", which separates blood into three 
layers, namely bottom-most layer containing RBC (55% of total volume), 
top most acellular layer called Platelet Poor Plasma- PPP  (40% of total 
volume), and an intermediate Platelet Rich Plasma layer (5% of total 
volume) called the "Buffy coat". 
3. Using a syringe PPP, PRP and some RBCs into another tube without an 
anticoagulant.  
4. This tube now undergoes a second centrifugation; it is longer and faster 
than the first one, so called "hard spin". This allows the PRP to settle at the 
bottom of the tube with a very few RBCs. The acellular plasma (80% of 
the volume) is found at the top. 
5. PPP is removed with a syringe and discarded and the remaining PRP is 
shaken well. 
 
 
6. This PRP is mixed with bovine thrombin & calcium chloride during the 
time of application which results in gelling of this platelet concentrate.  
 
SIDE EFFECTS OF PRP: 
                     Since it is an autologous preparation, PRP is inherently safe 
and therefore it is free from transmissible diseases such as HIV, Hepatitis 
etc. During the preparation of PRP calcium chloride and bovine thrombin 
are used. It has been found that the use of this bovine thrombin can lead to 
the development of antibodies to the factors V, XI and thrombin which 
results in the risk of life threatening coagulopathies. Bovine thrombin 
preparation contains factor V, which can result in the stimulation of 
immune system when challenged with a new protein. 
                      
PLATELET RICH FIBRIN (PRF): 
                               PRF was first developed by Choukroun et al in France. 
It is usually called as second generation platelet rich plasma. It has several 
advantages over traditionally PRP. The chief advantages are 
 The ease of preparation and  
 
 
 The absence of biochemical handling of the blood, which makes 
this preparation purely autologous. 
 
PREPARATION OF PRF: 
                          The preparation of PRF is very simple procedure. Since 
we do not use bovine thrombin for the preparation; PRF is free from the 
associated risks.  
 The required quantity of blood is taken into 10ml test tubes  
 No anticoagulant was added.  
 It was centrifuged immediately.  
 Blood is centrifuged using a tabletop centrifuge, which is easily 
available in most of the labs. 
 It is centrifuged for 12 min at 2,700 rpm.  
 
The resultant product consists of the following three layers: 
 Topmost layer consisting of acellular Platelet poor plasma. 
 PRF clot is in the middle 
 RBCs at the bottom  
                             
 
                    Because of the absence of the anticoagulant, blood begins to 
coagulate very soon when it comes in contact with the glass surface. So for 
successful preparation of PRF, quick blood collection and centrifuging it 
immediately before the clotting cascade is initiated is necessary. PRF can 
be applied to surgical site. In our study we have used this second 
generation platelet rich concentrate. The growth factor content (PDGF and 
TGF-β) was comparable in both PRF and PRP. PRF has many advantages 
over usually prepared PRP. It eliminates adding anticoagulant and 
neutralizing it. The addition of bovine-derived thrombin which promotes 
the conversion of fibrinogen to fibrin in PRP is also eliminated. All these 
steps considerably reduce biochemical handling of blood and reduce the 
risk associated with the bovine derived thrombin. The conversion of 
fibrinogen into fibrin occurs slowly with the available small quantities of 
physiological thrombin present in the blood sample itself. Thus there is a 
normal physiologic architecture which is very favorable to the healing 
which is obtained due to this slow polymerization process. 
                     For repairing the tympanic membrane there is always a 
search for new biomaterials or biological tissues which has a better 
outcome, lower cost, safety, structure similar to tympanic membrane.  
 
                  Though temporalis fascia and tragal perichondrium are 
commonly used graft material, there are lot of differences in outcome 
which depends upon experience of surgeon and patients own tissue repair 
response.  
                        
               ANATOMY OF MIDDLE EAR CLEFT 
                        The middle ear is an air-filled cavity formed by extension 
of the foregut into the analage of temporal bone. The expanding first 
pharyngeal pouch forms multiple cul-de-sacs that join to form a common 
airspace partitioned by the ossicular chain and its associated ligaments and 
mucosal folds. The resorption of mesenchymal tissue further expands the 
size of middle ear and mastoid into niches, various compartments, and 
bony tracts of air cells. These additional areas vary considerably among 
different individuals and between ears, also influenced by heredity, airflow 
via the Eustachian tube, and the disease in the early years of life. 
                         Middle ear cleft includes Tympanic cavity proper, mastoid 
air cell system and the Eustachian tube. 
There are 3 parts in the tympanic cavity namely  
 Epitympanum – Portion of the middle ear which is above the level 
of neck of malleus. 
 Mesotympanum – Portion of the middle ear that lies between the 
two horizontal lines drawn at the level of upper and lower edges of 
pars tensa of the tympanic membrane 
 Hypotympanum – Portion of the ear that lies below the level of 
bony ear canal. 
             
                                  Fig.1. Tympanic cavity 
                  
                    Roof of the tympanic cavity is formed by petrous part of 
temporal bone. It is called as Tegmen tympani. 
                   Floor of the tympanic cavity is a formed by a bone which 
separates it from the Jugular Bulb. 
                     Lateral wall is partly bony and partly membranous. Most of it 
is formed by Tympanic membrane. The lateral epitympanic wall is wedge 
shaped bone and its lower bony wall is called the SCUTUM (Shield of 
Liedy). 
The anterior wall mainly consists of three parts 
 Superiorly the opening for canal of Tensor tympani muscle 
 In the middle part there is an opening for auditory tube 
 Inferiorly there is a thin plate of bone which separates the middle 
ear from the internal carotid artery. This plate is traversed by the 
superior and inferior Carotico- tympanic nerves and the tympanic 
branches of internal carotid artery. 
                          
 
               The bony canal between the two tensor tympani and Eustachian 
tube continues posteriorly on the medial wall like a curved lamina which is 
called Proccessus cochleariformis. The posterior end of this process forms 
a pulley around which this tensor tympani muscle turns 90 degrees to get 
attached to the upper part of handle of malleus. 
               In the medial wall the most prominent structure that is visualized 
is Promontry which is actually the basal turn of cochlea. It is grooved by 
Tympanic plexus. Fenestra Vestibuli or Oval window is an oval shaped 
opening in the posterosuperior aspect of medial wall. This opening leads 
into the vestibule of the inner ear and it is closed by foot plate of stapes. 
Fenestra Cochleae or Round window is an opening in the bottom of the 
depression posteroinferior to the promontory. It opens into Scala tympani 
of the cochlea and it is closed by a thin membrane called secondary 
tympanic membrane. Facial nerve runs backward just above the oval 
window, towards the lower margin of additus. The canal then descends 
behind the posterior wall to end in Stylomastoid foramen. 
                   In the Posterior wall of the Tympanic cavity there is an 
opening in the superior part which is called as aditus, through which    
 
epitympanic recess communicates with mastoid antrum. Fossa incudis is a 
depression which lodges the short process of incus. There is a conical 
projection in the posterior wall called as pyramid with an opening in its 
apex. This opening transmits tendon of stapedius muscle which gets 
attached to the posterior surface of neck of stapes. Lateral to the pyramid 
and near the posterior edge of the tympanic membrane, there is posterior 
canaliculus for chorda tympani through which nerve enters the middle ear 
cavity. The space which is bounded laterally by vertical part of facial 
nerve and medially by promontory is called sinus tympani which can be 
the site of hidden cholesteatoma. Facial recess is the space which is 
bounded medially by the vertical part of facial nerve and laterally by 
tympanic annulus. 
ARTERIAL SUPPLY 
 Anterior tympanic branch of maxillary artery enters through the 
petrotymapnic fissure. 
 Posterior tympanic branch from stylomastoid branch of posterior 
auricular artery enters through the stylomastoid foramen. 
 
 Superior tympanic branch from the middle meningeal artery which 
enters through the tympanic canaliculus. 
 Tympanic branch from the artery of pterygoid canal enters through 
the canal for auditory tube. 
 Caroticotympanic branch from internal carotid artery 
 Petrosal branch from middle meningeal artery enters through the 
hiatus for greater petrosal nerve 
VENOUS DRAINAGE: 
Veins from the middle ear drain into 
 Superior petrosal sinus. 
 Pterygoid plexus of veins. 
LYMPHATIC DRAINAGE: 
Lymphatics drain to   
 Preauricular nodes. 
 Retropharyngeal nodes 
 
NERVE SUPPLY: 
                        Nerve supply is derived from the tympanic plexus which is 
present over the promontory. The plexus is formed by 
 Tympanic branch of glossopharyngeal nerve which is otherwise 
called as Jacobson’s nerve. It supplies mucous membrane of middle 
ear, Eustachian tube, mastoid antrum, and air cells. 
 Superior and inferior caroticotympanic nerves from the sympathetic 
plexus around internal carotid artery. These fibers are vasomotor to 
the mucous membrane. 
MIDDLE EAR MUCOSA: 
                             The middle ear mucosa is pseudo stratified ciliated 
columnar epithelium near the Eustachian tube and becomes cuboidal near 
the facial nerve. The epithelium is flat, pavement type in the attic region. 
Goblet cells present in the mucous membrane secrete mucus. Goblet cells 
are in higher concentration near the Eustachian tube. The mucous 
membrane lining the tympanic cavity forms various mucosal folds which 
divides it into numerous compartments. 
                      
                  Both the ossicular chain and associated mucosal folds partition 
the middle ear. Separation of mesotympanic and epitympanic regions is by 
the tensor fold, the interosseous fold and the medial incudal fold, leaving 
the isthmus tympani anticus and isthmus tympani posticus  as the only 
remaining openings. Other mucosal folds are obturatoria stapedis, plica 
stapedis,   superior incudal fold, anterior malleal fold, superior malleal 
fold, incisura tensoris, anterior malleal ligament, superior malleal ligament 
and posterior incudal ligament.  
There are various pouches and spaces which are formed as the result of 
these mucosal folds. 
PRUSSAK’S SPACE: 
 It is bounded  
 Laterally by pars flaccida 
 Medially by neck of malleus 
 Inferiorly by lateral process of malleus 
 Superiorly by lateral malleolar fold 
 
POSTERIOR POUCH OF VON TROELTSCH: 
                It lies in between the tympanic membrane and the posterior 
malleolar fold. It opens inferiorly. 
ANTERIOR POUCH OF VON TROELTSCH: 
                 It lies in between the tympanic membrane and the anterior 
malleolar fold. 
OSSICLES: 
                  There are 3 ossicles in the middle ear which conducts the sound 
from external ear to inner ear. They are Malleus, Incus and Stapes. 
Malleus 
It is the lateral and largest of the ossicles. It is about 8 to 9 mm long. It has 
the following parts 
1. Head – It is rounded and lies in the attic. It articulates posteriorly 
with the body of incus. It provides attachment to the superior and 
lateral malleolar ligaments. 
 
2. Neck – Lies against the pars flaccida and is related medially to 
Chorda tympani. 
3. Anterior process – It is connected to the petro tympanic fissure by 
the anterior malleolar ligament. 
4. Lateral process – It projects from upper end of the handle and 
provides attachment to the malleolar folds. 
5. Handle – Extends downwards, backwards and medially and it is 
attached to upper half of the tympanic membrane.  
Incus 
It has following parts 
1. Body – Large with its articular surface directing forwards. 
2. Short process – It is directed backwards and is fixed to fossa incudis 
just below the aditus. 
3. Long process – Projects downwards into the cavity just behind and 
parallel with the handle of malleus. Its tip bears a lentiform process 
which is directed medially to get articulated with stapes head. 
 
 
Stapes 
This is the medial most and smallest of the 3 ossicles. It has following 
parts 
1. Head – It is a small concave facet which articulates with the 
lentiform nodule. 
2. Neck – It is the narrowest part which provides insertion posteriorly 
to the thin tendon of stapes. 
3. Crura – They are 2 in number, the anterior and posterior one. The 
anterior crura is shorter and less curved. The limb diverges from 
neck and gets attached to the foot plate. 
4. Foot plate – It is oval in shape and fits into fenestra vestibuli. 
 
TYMPANIC MEMBRANE 
                                The tympanic membrane forms the medial limit of the 
External auditory canal and most of the lateral wall of the middle ear 
space. It is a three-layered, concave-shaped thin membrane connected 
centrally to the manubrium of handle of malleus and peripherally to the  
 
tympanic sulcus. The tip of the malleus is attachment produces a 
depression known as the umbo. 
                               Fibrous layer of the tympanic membrane is divided into 
two dense layers an outer layer and a deeper layer, which provide the 
structural support for thin EAC skin laterally and middle ear mucosa 
medially. The outer radial fibrous layer inserts on the manubrium of the 
malleus, and deeper circular fibrous layer is arranged circumferentially 
close to the circumference of the tympanic membrane. Both layers become 
integrated in the periphery to form a fibro cartilaginous ring, the annular 
ligament which anchors the tympanic membrane to a bony sulcus in the 
tympanic ring. This tympanic sulcus terminates superiorly at anterior and 
posterior spines, to which the most superior edge of the fibrous layer is 
attached to form posterior and anterior mallear folds that insert on the 
lateral process of the malleus. The small area of tympanic membrane 
located superior to the anterior and posterior mallear folds lacks a fibrous 
layer and is attached superiorly to the bony rim of the notch of Rivinus. 
The thinner superior segment of tympanic membrane is known as pars  
 
 
flaccida or Shrapnel’s membrane, and the thicker inferior area is known as 
pars tensa. 
                 The round window, long process of the incus, incudostapedial 
joint, and chorda tympani are identifiable through the intact tympanic 
membrane to varying extent, depending on its translucency, extent of its 
retraction, and the mucosal status within the middle ear. 
 
EUSTACHIAN TUBE: 
                         The Eustachian tube serves as the conduit through which 
atmospheric air is exchanged between the middle ear and upper aero 
digestive tract. It is angled about 45 degrees from the middle ear to the 
nasopharyngeal opening. The proximal one third of the tube is formed by 
petrous bone. The distal two third segment is formed by fibro cartilaginous 
tube. The fibro cartilaginous portion is an open tube that is shaped like an 
inverted “J” in its cross section. A fibrous membrane closes the tube 
laterally. The tensor veli palatini muscle gets inserted on to this membrane 
retracting it during muscular contraction to enlarge the  
 
lumen during swallowing and yawning. The bony-cartilaginous junction is 
the narrowest part of the Eustachian tube. The internal carotid artery is in 
close relation with the medial wall of the Eustachian tube near its 
tympanic opening, where sometimes the overlying bone may be very thin 
or even dehiscent. 
 
  
                   
 
                                           
                                        AIMS OF STUDY 
           To study the efficiency of use of autologous platelet rich plasma in 
closure of tympanic membrane perforation during myringoplasty by  
 Preventing the graft displacement. 
 Promoting quicker healing. 
 Improving the overall outcome. 
                                                                                           
 
 
 
 
 
 
                  MATERIALS AND METHODS 
 
STUDY DESIGN   
        Cohort study / Prospective Observational study of myringoplasty 
done in our institution during the study period. 
STUDY CENTRE& POPULATION          
          Study was conducted in patients who undergone myringoplasty at   
Government Kilpauk Medical College hospital and Government 
Royapettah hospital during the study period. 
STUDY PERIOD                                  
         November 2011 to December 2012. 
FINANCIAL   SUPPORT                     
         Self. 
INCLUSION CRITERIA 
 Chronic otitis media inactive mucosal disease (central perforation 
with dry ear) without discharge for at least 6 to 8 weeks 
EXCLUSION CRITERIA 
 Children below 12 years of age. 
 Active ear disease. 
  Atopic ear conditions. 
 Diabetes mellitus. 
 Other systemic illness like autoimmune disease, active neoplastic 
disease. 
 Patient on immunosuppressant drugs. 
  The above patients were excluded from the study. 
CONTROL GROUP 
          Patient in whom platelet rich plasma is not used for myringoplasty 
during the same study period are taken as control group. 
 
            
 
 
 
 
 
 
 PATIENT HISTORY 
                     History taking is very important as this gives valuable income 
regarding age at onset, drainage, Eustachian tube function, and previous 
surgery etc. 
                    Patient with chronic otitis media mucosal disease were 
randomly selected from the OPD of our institution. They were first 
subjected to examination under microscope. Otoscopic examination with 
the aid of microscope is the gold standard for diagnosis of COM 
(1)
.  
Microscopic examination is the most important aspect of the initial 
evaluation. It should be accomplished with the patient in the supine 
position. This allows an assessment of ear canal size in the surgical 
position, bend of the neck, shoulder elevation, anticipated comfort of the 
surgeon in a seated surgical position, and patient tolerance for 
examination. The contra lateral ear is carefully examined first and serves 
as a point of reference. The status of the middle ear mucosa in the surgical 
ear will dictate topical preoperative treatment.
(10)  This also facilitates aural 
toileting which can be done by suction, irrigation, mopping or instrumental 
removal. Under microscopic magnification all areas can be fully visualized  
 and perforation edges can be can be clearly seen. Ossicular chain status 
can be assessed. Findings like presence of granulation, in growth of 
squamous epithelium from edges of perforation, tympanosclerosis and 
adhesions can be seen. Though anatomically pars tensa is divided into four 
quadrants, pathologies like perforations are usually anterior, posterior or 
inferior. Hence division into thirds rather than quarters is preferred.  
 
                              
                                          Fig.2.Small central perforation 
                                  
 
                                  
                                                  Fig.3.Subtotal perforation 
                        Pus was sent for culture and sensitivity. The bacteriological 
culture is of potential value in starting specific antibiotics. All the patients 
with active ear disease were treated upto one month with specific 
antibiotics. 
                        Diagnostic nasal endoscope was done for all patients. Those 
who had nasal obstruction and features of chronic sinusitis were subjected 
to computerized tomography of paranasal sinus. Patients with symptomatic  
 septal deviation and chronic sinusitis initially underwent Functional 
endoscopic sinus surgery with septal correction. 
                        Pure tone audiogram is done in all patients which is helpful 
in assessing degree and type of hearing loss. Usually patients will have 
conductive hearing loss in this type of illness. It also helped us in deciding 
the ear to be operated first in case of bilateral disease. In case of bilateral 
disease usually more symptomatic and worse ear is operated first. It is 
important to assess whether there is any associated senosrineural hearing 
loss.  
                     After achieving dry ear for six to eight weeks patient is 
subjected to X-ray of both mastoids – Law’s view or lateral oblique view. 
X-ray showed sclerotic mastoid or clouding or air cells or cellular mastoid. 
Depending upon the X-ray finding the surgical procedure was planned. 
Patients with sclerosed mastoids and clouding of air cells underwent 
cortical mastoidectomy with myringoplasty with or without ossicular 
reconstruction. Patients with cellular mastoid underwent myringoplasty 
alone with or without ossicular reconstruction. 
 
                                    
                                                         Fig.4.cellular mastoids 
 
                                    
                                               Fig.5.sclerosed mastoids           
                   
                All the cases in whom cortical mastoidectomy with 
myringoplasty was done was performed under general anaesthesia. The 
two principal incisions used for access to the mastoid cortex are the post 
auricular incision of Wilde and the endaural incision of Lempert.
 (10)
 The 
post auricular incision provides better overall exposure and allows 
complete access to the mastoid tip. In adults, the incision is placed 8 to10 
mm posterior to the post auricular sulcus where it is hidden by the pinna. 
This incision can be placed more posterior for wider exposure. It should 
not be placed directly in the post auricular crease, however, because this 
creates a deep, difficult to clean post auricular furrow. In children younger 
than 2 years, the inferior portion of this incision must be placed more 
posterior than in adults. This is because the tympanic ring in children is 
underdeveloped, mastoid pneumatization is incomplete, and the 
stylomastoid foramen is quite shallow.    
                 Therefore, the facial nerve is vulnerable to injury. The surgeon 
should also keep in mind that congenital anomalies of the temporal bone 
can result in highly variable facial nerve position. 
                 
  
 The post auricular incision is first outlined with a marking pen. 
 
                                         
                                    Fig.6.William Wilde’s postaural incision 
                             
 
                       Infiltration is given with a mixture of local anesthetic and 
epinephrine. The skin and subcutaneous tissues are incised sharply down 
to the periosteum overlying the mastoid cortex. The ear flap is elevated 
anteriorly to identify the posterior edge of the external ear canal. 
 
 
  
TEMPORALIS FASCIA HARVESTING: 
                     In 1959, kley first described using muscle fascia for closing 
tympanic membrane perforation. The temporalis fascia can be taken from 
the operative field in both transmeatal and post auricular approach. 
Incision was extended superiorly and temporalis fascia graft is harvested. 
The fascia 1 cm above the supramastoid crest is usually preferred because 
it is thin and suitable for grafting the tympanic membrane. Fat adhered to 
the fascia is removed. Smooth muscle side of fascia should be turned 
inside the middle ear while placing the graft. Before placing the fascia it 
should be allowed to dry so that it can get adapted better. 
 
                                  
                                        Fig.7.Temporalis fascia graft 
                         
                         
                       The incision is then extended into the subcutaneous tissue. 
Soft tissue and post auricular muscles are divided. A T-shaped incision is 
made through the soft tissues and periosteum overlying bone. The superior 
limb is placed along the inferior temporal line (inferior margin of the 
temporalis muscle) starting at a point just superior to the anterior-superior 
ear canal. This incision extends posterior as far as is needed for adequate 
exposure. An inferior limb to the T- is fashioned from the mastoid tip to 
the superior limb just described.  
                         Periosteal elevators are then used to elevate the periosteum 
of the mastoid cortex toward the posterior margin of the ear canal. 
Superior to the ear canal, the periosteum should be elevated anteriorly 
along the zygomatic root. Inferior to the ear canal, the surgeon should 
elevate periosteum to the anterior margin of the superior aspect of the 
mastoid tip. Periosteum and meatal skin are elevated. The meatal skin is 
now incised about 5 to 6 mm from the edge of the tympanic membrane. 
Edges of the perforation are freshened and tympanomeatal flap is elevated. 
Ossicular chain status is noted. The mastoid is opened through its cortical 
surface with a drill.  
                                                           
 
                           Fig.8.showing cortical mastoidectomy is being performed 
         
                   The temporal line, spine of Henle, cribrose area, and posterior 
ear canal are used as the initial landmarks for drilling. Mastoid antrum is 
usually located at a distance of 1 to 1.5 cm from the surface of the mastoid 
cortex. After opening the antrum, additus is widened and drainage  
 established. It is followed by myringoplasty by underlay technique with or 
without ossiculoplasty. 
UNDERLAY MYRINGOPLASTY TECHNIQUE: 
 Skin incision made in post auricular fold or behind the fold. 
 Soft tissues and postaural muscles are cut and periosteum is elevated 
as described earlier. 
 Tympanomeatal flap is elevated after incision around edge of 
perforation has been made. 
                        
 
                                       Fig.9.Tympanomeatal flap elevation 
  
 Ossicular chain status is examined. 
 After clearing the disease in the middle ear, the fascia is laid in the 
tympanic membrane from the middle ear side, overlapping the 
perforation on all edges. 
 Tympanomeatal flap is repositioned. 
 
 
              
 
                                          Fig.10.Underlay myringoplasty done 
 
  Second generation Platelet rich concentrate, the platelet rich fibrin 
was prepared and it is applied to the edges of perforation and ear 
canal packed with gel foam 
                             
                                                 
                                  Fig.11.platelet rich fibrin preparation.                   
  
      
                    The superficial platelet poor plasma layer is removed and the 
middle layer which is a Buffy coat containing platelet clot is taken out. 
 
                                       
 
                                  Fig.12.Middle PRF layer 
 
 
ENDOSCOPIC APPROACH: 
 
                            Endoscopic myringoplasty was done in few of our 
patients with wide canal and small perforation. Endoscopes often see 
where the microscope cannot. The surgeon's view through the operating 
microscope depends on a clear line of sight. A 30-degree rigid telescope,  
 however, can look around a corner to visualize the facial recess, sinus 
tympani, or epitympanum. 
                              All the patients were under antibiotic cover in the 
postoperative period. Sutures were removed on 7
th
 postoperative day and 
patients were given oral antibiotics and antihistamines. Patients were on a 
regular follow up every 15 days for 3 months. 
 
  
                         REVIEW OF LITERATURE 
 
             The UK national study of hearing has examined the relationship 
between chronic otitis media and age, sex and socioeconomic status
 (1). 
                According to their study the prevalence of COM is equal in 
males and females. The incidence is double in 41 to 80 years age group as 
compared to 18 to 40 years age group. 
                The disease is more common in low socioeconomic status. The 
manual workers are twice commonly affected than the nonmanual 
workers. 
                The population prevalence of inactive COM in 18 to 40 years 
age group is 2.5 and active COM is 0.9. In 41 to 60 years age group 
inactive COM is 2.1 and active COM is 2.1 and in 61 to 80 years age 
group inactive COM is 2.7 and active COM is 2.1. This study concludes 
that the disease is common in 41 to 80 years age group. 
                 The population prevalence of inactive COM in manual workers 
is 2.8 and active COM is 2.2, whereas in nonmanual workers it is 1.9 and 
0.8 respectively. 
             
             In 1982 a prospective study about the bacteriology in chronic otitis 
media was conducted by Sweeney G Picozzi GL, Browning GG 
(1)
. 
              According to their study 64 percent of culture had only aerobes, 
32 percent both aerobes and anaerobes and 5 percent had no growth. They 
also observed that in those patients with aerobes, most of them had several 
isolates with a mean of 2.5 different aerobes.  
              The common aerobic bacteria isolated from patients with active 
COM were proteus species which is seen in most of the cases followed by 
staphylococcus aureus and pseudomonas. Proteus species was seen in 
almost 95% of ear isolates with aerobic infection. 
              So they concluded that microbiology culture usually yield 
multiple organisms and it depends on patient population, climate, whether 
antibiotic has been used or not.  
 
- Michael Gleason/ Scott Brown’s, otorhinolaryngology head and 
neck surgery – 7th edition - page 3408 – 3410. 
 
                   A study conducted by Bluestone et al in 1989 to study the 
relationship between Eustachian tube and middle ear disease 
(19)
. 
                   He found that Eustachian tube dysfunction is the main cause 
for middle ear disease. He stated that diseases in the sinuses like chronic 
sinusitis and other upper respiratory tract infection is the common cause 
for Eustachian tube dysfunction. According to his study adenoids are less 
common cause for Eustachian tube dysfunction as compared to sinus 
disease. 
                  The lining mucous membrane of middle ear continues with that 
of Eustachian tube. The membrane is also same in sinuses, nose and throat. 
Any infection in these areas will cause mucosal swelling which in turn can 
lead to Eustachian tube mucosal swelling. 
                So in case of persistent otorrhea if there is associated sinus 
disease it is necessary to treat the sinus disease first to achieve a positive 
outcome. 
                          
  
  
                  A pilot study is being conducted by Maria Lucia Navarrete 
Alvaro on efficiency of biostimulation with autologous plasma rich in 
platelet growth factors in myringoplasty. It’s an ongoing prospective, 
longitudinal, observational study at university of Barcelona, Spain 
(3)
. 
                   They performed Type I Tympanoplasty using a PRP graft from 
the own patient, obtained at the Blood and Tissue Bank. They did on lay 
myringoplasty which is technically simpler method with lower morbidity 
for the patient and a perforation seal guarantee.  
                   Three patients with chronic otitis media inactive stage have 
been selected for the study and procedure was done. The results were 
valued based on the tympanic membrane closure index.  
                     According to their study the tympanic membrane closure 
index was good and preliminary results of these patients were satisfactory. 
In all three cases, the perforation closed completely. 
                      
                      
 
                    A study was conducted by  Mehmet Habesoglu M.D.;  Cagatay 
Oysu M.D. et al to investigate the effect of Choukroun’s Platelet rich 
fibrin on the acute tympanic membrane perforation due to trauma 
(4)
. 
                    It is a prospective controlled study which was conducted in 
2011. Thirty two patients with acute tympanic membrane perforation were 
selected and they were randomly divided into two groups. The study group 
had 14 patients and control group had 18 patients. 
                     Platelet rich fibrin was used to repair the tympanic membrane 
perforation in the study group. In control group no manipulation was done. 
Mean area of perforation was 10.93±3.58 mm
2
 in the study group and 
10.05±4,02 mm2 in the control group in the first examination. At the end 
of 1st month the mean area of the perforation was 1.35±2.53 mm
2
 in the 
study group and 4.44±3.34 mm2 in the control group (P<0.01). Total 
closure rate of the tympanic rates was 64.3 % for the study group, and 
22.2% for the control group (P<0.05) at the end of 1
st
 month.  
 
 
                       
                      At the end of 2
nd
 month, number of patients with a 
perforation was one for the study group, 4 for the control group (P>0.05). 
At the end of the second month, 7.1% of patients in the study group had 
unclosure of the tympanic membrane, 22.2% patients in group-2 had 
unclosure of their tympanic membrane (P>0.05). 
                     Their study concluded that platelet rich fibrin is easy to 
prepare biomaterial and autologous platelet concentrate which has 
enriched growth factors accelerates the healing of tympanic membrane. 
 
 
     
               
 
 
 
 
 
 
 
 
                    An experimental study was conducted by Erkilet E in 2008 to 
study the effect of local application of platelet rich plasma in healing of 
tympanic membrane perforations. The healing time and histopathological 
outcome was studied. This study was conducted in rats
 (13)
. 
                 Forty four rats were selected and both side tympanic 
membranes were given standard 3 mm cuts. Platelet rich plasma was 
applied to right tympanic membrane and they were taken as cases. Left 
tympanic membrane was allowed to heal spontaneously and taken as 
controls.  
                     The mean tympanic membrane healing time in tympanic 
membranes receiving platelet rich plasma is 10.2 +/- 2.1 days, where as in 
control group it is 13.0 +/- 2.9 days. This study was statistically significant as 
they had a P value of <0.001. 
                         They concluded that platelet rich plasma accelerates the 
tympanic membrane healing and it may be effective as an autologous 
material in healing of tympanic membrane perforation in human subjects 
also.                        
 
                 RESULTS 
 
Our study population had 50 patients out of which 25 were cases and 
remaining 25 were controls 
                                                   Table 1 
        Age distribution of COM patients in the study population  
 
          Age  
 
Total no of patients 
 
        Percentage  
 
      13 – 20 yrs 
 
               8 
 
               16 
 
      21 – 25 yrs 
 
              10 
 
               20 
 
      26 – 30 yrs 
 
              11 
 
               22 
 
      31 – 35 yrs 
 
               5 
 
               10 
 
      36 – 40 yrs 
 
               7 
  
               14 
 
     40 – 45 yrs 
 
               5 
 
               10 
 
     46 – 50 yrs 
 
               2 
 
                 4 
 
     >50 yrs 
 
               2 
 
                 4 
 
       Total  
 
              50 
 
              100 
 
               
             In our study majority of cases belonged to young adults between 
21 to 30 years of age. 
               
            Figure 13 - showing the age distribution in study population 
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                                      Table 2 
                 Economic status of the patients in the study group 
 
 
Economic   
status 
 
Upper  
class 
 
Middle  
class 
 
Lower  
class 
 
  Total  
 
No of case 
 
    1 
 
   13 
 
   36 
  
      50 
 
Percentage  
 
    2 
 
   26 
 
   72 
 
     100 
 
 Table 2 shows the economic status of the study group. 
 
 
             Figure 14 Graphical representation of economic status 
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                                                       Table 3 
                         Sex wise distribution of the study group 
 
 
             Sex  
 
    No of patients 
 
    Percentage 
  
            Male  
 
             20 
 
         40 
  
           Female  
 
             30 
 
         60 
 
           Total  
 
             50 
 
        100 
 
 
                      Figure 15 showing Gender distribution 
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                                      Table 4 
                           Unilateral vs. bilateral disease 
 Unilateral ear disease Bilateral ear disease  
        cases              19              6 
        controls              23              2 
        Total               42              8 
        Percent               84             16 
 
       Table 4 shows the disease pattern in cases and controls. 
         
       Figure 16 shows the disease pattern in cases and control group 
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                                               Table 5  
                                Size of perforation in cases 
  Type of perforation        No of patients         percentage 
   Small              2                8 
   Medium              7               28 
   Large              6               24 
   Subtotal             10               40 
 
                                               
                                             Table 6 
                            Size of perforation in controls 
Type of perforation      No of patients      percentage 
    Small              3            12 
    Medium              2              8 
    Large             11             44 
    Subtotal               9             36 
 
                The above tables indicate the various types of central perforation 
in the study group. 
 
              Figure 17 showing size of the perforation in cases and control 
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                                           Table 7  
                          Showing degree of hearing loss 
 
        Degree   In Unilateral disease           In Bilateral disease 
       Mild                 29             Both ears – 5  
            Right ear – 1  
            Left ear – 2  
      Moderate                 11            Both ears – 0 
           Right ear – 2 
           Left ear –   1 
      Severe                   2             Nil  
 
         Table 7 shows the degree of hearing loss baased on pure tone 
audiogram finding. 
 
                 
                      Figure 18 showing degree of hearing loss 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
mild moderate severe mixed
hearing loss in bilateral disease
hearing loss in unilateral 
disease
                                          Table 8 
                          Patients who underwent FESS 
       No of patients 
            Cases                 2 
            Control                 3 
           Total                 5 
 
                    Table 8 shows number of COM patients having sinus disease 
who underwent FESS to clear the septic foci. 
            
         Figure 19 showing patients who underwent sinus surgery 
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                                           Table 9 
Cortical mastoidectomy with myringoplasty vs. Myringoplasty alone 
     Procedure     Control      Cases      Total 
Myringoplasty         6        12       18 
Cortical   
mastoidectomy with 
myringoplasty 
 
         19 
 
         13 
 
      32 
 
         
     Figure 20 Schematic representation of type of surgical procedure 
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Table 10 
                                Ossicular chain status 
Ossicle 
disrupted 
     Cases        Control       Total  
      Malleus           1             2          2 
      Incus           7             3          11 
      Stapes           0                 0           0 
 
  
          Figure 21 Showing ossicular chain statuses in the study group 
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                                             Table 11 
                            Anaesthesia during surgery 
 No of patients     percentage 
 General  
anaesthesia 
          46            92 
 Local  
anaesthesia 
            4              8 
      Total             50           100 
 
             Table 11 shows number of patients who are operated under 
general or local anaesthesia. 
                   Figure 22 showing anaesthesia during surgery 
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                                                 Table 12 
                                          Final outcome 
           Cases          Controls  
No of patients              25                 25 
Tympanic membrane  
closure 
 
Cases 
 
       24 
 
Controls 
 
    20 
  
Percent 
 
       96 
 
Percent 
 
    80 
Failure                 1                  5 
   
                 Figure 23 showing the outcome of surgery 
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                                  DISCUSSION   
                                 
                           In our study out of the 50 patients who underwent surgery, 30 
were females (60 percent) and 20 (40 percent) were males. This is in 
contrast to UK national study of hearing; according to them the incidence 
is equal in both male and female. 
                     The age of distribution of chronic otitis media in our study 
population was compared with the previous data. It shows that the disease 
is common in 20 to 30 yrs age group in our study population whereas 
according to UK national study of hearing it is common in 41 to 80 years 
age group. 
                              The disease is common in lower socioeconomic groups 
which is similar to the previous literature review. In our study only one 
patient out of 50 patients belong to higher socioeconomic status, whereas 
about 72 percent of patients were from lower class and 26 percent of 
patient belongs to middle class, which again reflects the prevalence of this 
disease in lower class. The increased incidence of this disease in this lower 
class is due to overcrowding, poor sanitation, poor nutrition and illiteracy. 
                      
                   About 84 percent (42 patients) of people in the study 
population had unilateral ear disease whereas remaining 16 percent (8 
patients) had bilateral disease. In cases 19 patients had unilateral disease 
and 6 patients had bilateral disease. In controls 23 patients had unilateral 
disease whereas 2 patients had bilateral disease. Among the unilateral 
disease in controls 13 patients had right ear disease whereas 10 patients 
had left ear disease. Among cases 7 patients had right ear disease and 12 
patients had left ear disease. Bilateral disease is commonly due to bilateral 
Eustachian tube dysfunction. 
                         In our study large and subtotal perforation is very common 
in comparison to other perforations. Among cases 2 patients had small 
perforation, 7 patients had medium, 6 patients had large and 10 patients 
had subtotal perforation. In controls 3 small, 2 medium, 11 large and 9 
subtotal perforations was seen. According to the study conducted by 
Braccini F regarding the relevance of Choukroun's Platelet-
Rich Fibrin (PRF) during middle ear surgery residual perforations were 
noticed in 4 percent of cases, all of them had large perforation 
preoperatively. Out of 6 failures in our study 5 occurred in large/ subtotal 
perforations which similar to the above study. 
                   
                    In our study population most of the patient had mild 
conductive hearing loss. Among the unilateral disease patients, 29 had 
mild conductive hearing loss, 11 had moderate conductive hearing loss 
where as 2 had mixed hearing loss. Among bilateral disease both ears 
having mild conductive hearing loss was seen in 5 patients. Right ear 
having mild conductive loss is seen in 1 patient, and left ear having mild 
loss is seen in 2 patients. Moderate conductive hearing loss was seen in 
right ear in 2 patients and in left ear in one patient. None of the patient 
with bilateral ear disease had mixed hearing loss. 
                           According to study conducted by Bluestone et al, sinus 
disease is one of the important causes for Eustachian tube dysfunction 
which can lead to chronic otitis media. Treating the sinus disease along 
with the ear disease is very important to get complete cure. In our study 5 
patients (2 cases and 3 controls) with ear discharge even after the medical 
management had features of chronic sinusitis. CT scan was taken and they 
all underwent Functional Endoscopic sinus surgery. All patients had 
improvement in ear discharge after sinus surgery and subsequently they 
underwent ear surgery. 
                            
                            X – ray both mastoids was the important investigation 
based on which surgery for the patient is decided. All patients underwent 
this investigation after attaining dry ear for 6 to 8 weeks.  Among cases 12 
patients had well pneumatised mastoids, they underwent myringoplasty 
and 13 had sclerosed mastoids or clouding of air cells, they underwent 
cortical mastoidectomy with myringoplasty. Among control 6 patients had 
well pneumatised mastoids whereas 19 had sclerosed mastoids. 
                           Ossicular chain discontinuity was noted in 13 patients in 
the study population. Among them incus problem was seen in most of the 
cases. 7 patients among cases and 3 patients among controls had incus 
erosion, commonly the long process. Malleus problems were seen in 1 
case and 2 controls. None of the patients had stapes problems. 
Ossiculoplasty was done in all these patients. Homograft’s like remnant 
ossicles and cartilage were commonly used. 
                         All the patients who underwent cortical mastoidectomy 
with myringoplasty were operated under general anaesthesia. Local 
anaesthesia was done in 4 cases that underwent myringoplasty alone. 2 
patients among cases and 2 among controls were operated under local  
 
anaesthesia. They were operated using transcanal endoscopic approach. 
All 4 patients had wide canal with posterior quadrant perforation. There is 
no risk of general anaesthesia complications and no postaural wound or 
hematoma. Overall there is reduction in post operative morbidity of the 
patient by this approach. 
                            The graft take up rate in our study is comparable with the 
reference studies. According to Maria Luisa Navarrete Alvaro use of 
platelet rich plasma during myringoplasty had a satisfactory result. A study 
was conducted by Mehmet Habesoglu M.D in 2011 among 32 patients 
with acute tympanic membrane perforations. He concluded that use of 
platelet rich fibrin accelerated the tympanic membrane closure. In our 
study among 25 cases that underwent myringoplasty with use of platelet 
rich fibrin, 24 had complete tympanic membrane closure and only one 
failure has been noticed. In controls 5 out of 25 cases had failure. At the 
end of first month follow up, 72 percent of cases had closure of tympanic 
membrane, while only 40 percent of controls had tympanic membrane 
closure. At the end of second month 92 percent of cases had closure while 
only 72 percent of control had closure. At the end of 3 months 96 percent 
of cases had closure, whereas only 80 percent of control had closure. Thus  
 
Our study shows that autologous platelet concentrates accelerates the 
tympanic membrane closure. 
                       Among cases, only one failure is noted which is due to 
infection. Among controls, 5 failures were noted 4 of them due to graft 
displacement and one due to infection. According to   Maria Luisa 
Navarrete Alvaro use of platelet rich plasma during myringoplasty will 
prevent graft displacement, which is seen in our study also. 
 
                     
 
 
 
 
 
                       
  
 
                                    CONCLUSION 
          
                Our study concludes the following 
 Platelet rich plasma is a cheap and cost effective platelet 
concentrate with enriched growth factors. 
 It accelerates the tympanic membrane closure following 
myringoplasty. 
 It prevents graft migration.  
 It improves the overall success rate of myringoplasty.  
 It has no noticeable side effects.  
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ANNEXURE 
PROFORMA 
 
Name:                                           Age:                                         Sex: 
IP/OP.No: 
Address: 
Occupation: 
Chief Complaints: 
 
EAR 
A. Discharge 
I. Duration 
II. Onset 
III. Nature 
IV. Colour 
V. Amount 
VI. Smell 
VII. Blood stained 
VIII. Aggravating / Relieving Factors 
IX. Associated Symptoms 
B. Hard of Hearing 
Onset 
Unilateral / Bilateral 
Gradual / Fluctuating 
C. Earache 
D. Vertigo / Tinitus 
 
NOSE 
A. Nasal Obstruction 
- Unilateral / Bilateral 
- Continuous / Intermittent 
B. Nasal Discharge 
- Unilateral / Bilateral 
- Scanty / Profuse 
- Colour 
- Smell 
C. Headache 
D. Anosmia 
E. Post Nasal Drip 
 
F. Sneezing 
H/o Previous Treatment – Medical / Surgical 
 
Clinical Examination: 
EAR                                                         Right                                   Left 
Pinna 
Preauricular Region 
Postauricular Region 
External Auditory Canal 
Tympanic Membrane 
Perforation 
Site 
Size 
Small 
Large 
Subtotal 
Middle Ear Mucosa 
Moist 
Boggy (Polypoidal) 
 
NOSE 
Anterior Rhinoscopy 
Posterior Rhinoscopy 
Sinus Tenderness 
Cold Spatula Test 
 
THROAT 
Tonsils – Normal / Hypertrophied / Shrunken 
Posterior Pharyngeal Wall – Normal / Granular / Congested / 
Postnasal Drip 
 
OTOENDOSCOPY 
1. Perforation : Small / Large / Subtotal 
2. Ear Discharge: Scanty / Copious 
3. Middle Ear Mucosa: Moist / Boggy 
 
 
 
DIAGNOSTIC NASAL ENDOSCOPY: 
First Pass                              Right                                                    Left 
Turbinoseptal 
Classification 
Inferior Turbinate 
Ridges / Spicules 
Eustachian Tube Orifice 
Mucosa 
Movement 
Secretions 
Nasopharynx 
Choana 
Others 
Second Pass 
Head of Middle Turbinate 
Uncinate Process 
Ethmoidal Bulla 
Accessory Ostia 
Middle Meatus Discharge 
Third Pass 
Sphenoethmoidal Recess 
Superior Turbinate 
Superior Meatus 
Others 
 
PLAN 
Medical management: 
Surgical management : Myringoplaty / Cortical mastoidectomy with  
myringoplasty / FESS followed by cortical mastoidectomy / myringoplasty 
 
POST OP FOLLOWUP 
  
  
MASTER CHART - CASES  
 S .no 
Name ,Age ,Sex 
OP/IP No 
Diagnosis Procedure 
Date of 
surgery 
Investi
gation 
Anaes
thesia 
Complica
tion 
Follow up 
1 
Ammu ,46/f 
5617 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
14/03/12 N GA Nil Graft taken well 
2 
Kanimozhi ,19/f 
5118 
B/L CSOM with CP Lt myringoplasty 02/03/12 N LA Nil Graft taken well 
3 
Sangeetha ,13/f 
964 
Lt CSOM with CP Lt myringoplasty 01/02/12 N GA Nil Graft taken well 
4 
Renuka ,23/f 
3044 
Lt CSOM with CP Lt myringoplasty 05/02/12 N GA Nil Graft taken well 
5 
Sagar ,13/m 
5465 
Lt CSOM with CP Lt myringoplasty 12/03/12 N GA Nil Graft taken well 
6 
Sathya ,17/f 
10606 
B/L CSOM with CP Lt myringoplasty 09/04/12 N GA Nil Graft taken well 
7 
Manjula ,36/f 
13823 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
21/05/12 N GA Nil Graft taken well 
8 
Bhavani ,44/f 
249202 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
16/12/11 N GA Nil Graft taken well 
9 
Abdulla  ,47/m 
269641 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
19/12/11 N GA Nil Failure  
10 
Sofiya ,20/f 
29186 
B/L CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
26/12/11 N GA Nil Graft taken well 
11 
Suryakala, 52/f 
29189 
B/L CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
30/12/11 N GA Nil Graft taken well 
12 
Naveen kumar ,18 /m 
458 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
09/01/12 N GA Nil Graft taken well 
13 
Aneesha ,28/f 
994322 
B/L CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
06/03/12 N GA Nil Graft taken well 
14 
Zeenath farhana,40/f 
995965 
B/L CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
30/03/12 N GA Nil Graft taken well 
15 
Ganga ,20/f 
996222 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
03/04/12 N GA Nil Graft taken well 
16 
Akthar basha ,25/m 
995619 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
20/03/12 N GA Nil Graft taken well 
 S .no 
Name ,Age ,Sex 
OP/IP No 
Diagnosis Procedure 
Date of 
surgery 
Investi
gation 
Anaes
thesia 
Complica
tion 
Follow up 
17 
Raja , 24/m 
992044 
Lt CSOM with CP Lt myringoplasty 03/02/12 N GA Nil Graft taken well 
18 
Soundarya ,28/f 
993610 
Rt CSOM with CP Rt myringoplasty 17/02/12 N LA Nil Graft taken well 
19 
Vennila ,22/f 
995750 
Rt CSOM with CP Rt myringoplasty 27/03/12 N GA Nil Graft taken well 
20 
Mumtaz ,27/f 
994107 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
02/03/12 N GA Nil Graft taken well 
21 
Priya ,34/f 
103118 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
13/07/12 N GA Nil Graft taken well 
22 
Shakira begham ,22/f 
104711 
Lt CSOM with CP Lt myringoplasty 07/08/12 N GA Nil Graft taken well 
23 
Neela ,30/f 
105625 
Rt CSOM with CP Rt myringoplasty 21/08/12 N GA Nil Graft taken well 
24 
Sarala ,36/f 
991794 
Lt CSOM with CP Lt myringoplasty 31/01/12 N GA Nil Graft taken well 
25 
Balaji ,27/m 
489 
Lt CSOM with CP Lt myringoplasty 07/02/12 N GA Nil Graft taken well 
 
  
  
 
 
 
 
 
 
MASTER CHART - CONTROL  
  
S no 
Name ,age,sex 
OP/IP no 
Diagnosis Procedure 
Date of 
surgery 
Investi 
gation 
Anaes 
thesia 
Compli 
cation 
Follow up 
1 
Murugan ,36/m 
23456 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
30/01/12 N GA Nil Graft taken well 
2 
Malathy ,18/f 
1439 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
06/02/12 N GA Nil Graft taken well 
3 
Sukumar, 42/m 
2151 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
16/02/12 N GA Nil Failure  
4 
Saravanan ,35/m 
5019 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
24/02/12 N GA Nil Graft taken well 
5 
Kumar ,24/m 
4628 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
27/02/12 N GA Nil Graft taken well 
6 
Elumalai ,32/m 
3119 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
05/03/12 N GA Nil Graft taken well 
7 
Ramesh ,32/m 
5610 
Rt CSOM with CP Rt myringoplasty 09/03/12 N GA Nil Failure  
8 
Jiyauddin ,60/m 
5490 
B/L CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
02/04/12 N GA Nil Graft taken well 
9 
Suseela ,33/f 
7150 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
26/03/12 N GA Nil Graft taken well 
10 
Sudalai,40/m 
3782 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
02/04/12 N GA Nil Graft taken well 
11 
Sheela ,22/f 
8559 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
09/04/12 N GA Nil Graft taken well 
12 
Devi ,42/f 
10515 
Rt CSOM with CP Rt myringoplasty 30/04/12 N LA Nil Graft taken well 
13 
Manikandan,21/m 
12148 
Lt CSOM with CP Lt myringoplasty 07/05/12 N GA Nil Graft taken well 
14 
Suja ,40/f 
16031 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
16/12/11 N GA Nil Graft taken well 
15 
Lakshmi ,23/f 
14822 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
20/12/11 N GA Nil Graft taken well 
 S no 
Name ,age,sex 
OP/IP no 
Diagnosis Procedure 
Date of 
surgery 
Investi 
gation 
Anaes 
thesia 
Compli 
cation 
Follow up 
16 
Rajeswari ,39/f 
8275 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
30/12/11 N GA Nil Failure  
17 
Gowri ,36/f 
14304 
Rt CSOM with CP Rt myringoplasty 06/01/12 N LA Nil Graft taken well 
18 
Jeganathan ,21/m 
3690 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
06/01/12 N GA Nil Graft taken well 
19 
Senthil kumar,27/m 
11902 
Rt CSOM with CP Rt myringoplasty 10/01/12 N GA Nil Failure  
20 
Padmavathy ,30/f 
6258 
Rt CSOM with CP Rt myringoplasty 13/01/12 N GA Nil Graft taken well 
21 
Sundaramoorthy,27/m 
992306 
B/L CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
10/02/12 N GA Nil Graft taken well 
22 
Usha ,30/f 
992842 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
14/02/12 N GA Nil Graft taken well 
23 
Mariappan ,28/m 
996606 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
10/04/12 N GA Nil Graft taken well 
24 
Thara ,45/f 
997056 
Rt CSOM with CP 
Rt cortical mastoidectomy 
with myringoplasty 
17/04/12 N GA Nil Failure  
25 
Sathish kumar,30/m 
997288 
Lt CSOM with CP 
Lt cortical mastoidectomy 
with myringoplasty 
20/04/12 N GA Nil Graft taken well 
 
  
  
